Jounce Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Jounce Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2018 to 2022.
  • Jounce Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.16M, a 22.3% decline year-over-year.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $4.67M, a 4.66% decline from 2021.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $4.9M, a 21.7% increase from 2020.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $4.02M, a 5.76% decline from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $4.67M -$228K -4.66% Jan 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
2021 $4.9M +$872K +21.7% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 $4.02M -$246K -5.76% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $4.27M +$4.27M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.